Liquid Biopsy Companies and Organizations

 

21 Organization(s)

AmoyDx

Business Area(s): 
Description: 

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. 

Angle

Business Area(s): 
Description: 

ANGLE’s lead product is the Parsortix™ cell separation system, which can capture very rare cells from blood. This includes circulating tumor cells (CTCs) in cancer patient blood – even when there ...

Celsee

Business Area(s): 
Description: 

Celsee’s C-Prep platforms are nanofluidic chips containing tens of thousands to hundreds of thousands of individual cell-capture wells. Characterization assays can be performed on-chip or viable ...

Circulogene Theranostics

Business Area(s): 
Description: 

Circulogene's “liquid biopsy” is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene's liquid biopsy tumor DNA sequencing is the only ...

GeneCast

Business Area(s): 
Description: 

Provides DNA sequencing services for liquid biopsy in detecting cancer and cancer mutations. 

GRAIL

Business Area(s): 

Guardant Health

Business Area(s): 
Description: 

The company makes blood tests that can be used to detect cancer an mutations in tumors related to drug resistance.

HaploX Biotechnology

Business Area(s): 
Description: 

Tumor Liquid Biopsy with Ultra-micro DNA

Hummingbird Diagnostics

Business Area(s): 
Description: 

Hummingbird Diagnostics is developing liquid biopsy diagnostics for early disease detection, 

Inivata

Business Area(s): 
Description: 

Inivata is a global clinical cancer genomics company utilizing an industry-leading liquid biopsy platform to transform patient care.

Karius

Business Area(s): 
Description: 

The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient’s bloodstream

Lexent Bio

Business Area(s): 
Description: 

Developing a liquid biopsy platform.

Nucleix

Business Area(s): 
Description: 

Nucleix has developed a method to read DNA Methylation changes.

NuProbe

Business Area(s): 
Description: 

NuProbe technology utilizes DNA toehold probe systems based on the fundamental engineering principle of molecular competition and precisely balanced thermodynamics and its application to rare ...

Personal Genome Diagnostics

Business Area(s): 
Description: 

Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based ...

Pillar Biosciences

Business Area(s): 
Description: 

Pillar Biosciences was founded on the belief that one day we can bring the eradication of cancer closer to a reality. Our team believes that by accelerating access to NGS adoption in labs, any NGS ...

Precipio Diagnostics

Business Area(s): 
Description: 

Precipio Diagnostics develops the ICE COLD-PCR (Ice Cold PCR) technology, claimed to preferentially enrich mutant DNA sequences in an excess of wild-type DNA through selective amplification of the ...

Predicine

Business Area(s): 
Description: 

Develops liquid biopsy solutions. 

RareCyte

Business Area(s): 
Description: 

RareCyte is a life science company that has developed technologies for the analysis of rare, single cells in blood. We believe that rare circulating cells hold valuable answers to important ...

Singlera Genomics

Business Area(s): 
Description: 

Singlera Genomics is committed to the application of next generation sequencing to diagnose genetic diseases and disorders. Singlera Genomics develops non-invasive genetic tests using proprietary ...

Vortex Biosciences

Business Area(s): 
Description: 

Circulating Tumor Cell Identification

Don't see an employer? Please fill out the form